282 related articles for article (PubMed ID: 9687390)
1. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models.
Theodos CM; Griffiths JK; D'Onfro J; Fairfield A; Tzipori S
Antimicrob Agents Chemother; 1998 Aug; 42(8):1959-65. PubMed ID: 9687390
[TBL] [Abstract][Full Text] [Related]
2. The immunomodulatory activity of secnidazole-nitazoxanide in a murine cryptosporidiosis model.
Madbouly N; El Amir A; Abdel Kader A; Rabee I; Farid A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33625354
[No Abstract] [Full Text] [Related]
3. Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model.
Li X; Brasseur P; Agnamey P; Leméteil D; Favennec L; Ballet JJ; Rossignol JF
Folia Parasitol (Praha); 2003 Mar; 50(1):19-22. PubMed ID: 12735719
[TBL] [Abstract][Full Text] [Related]
4. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa.
Doumbo O; Rossignol JF; Pichard E; Traore HA; Dembele TM; Diakite M; Traore F; Diallo DA
Am J Trop Med Hyg; 1997 Jun; 56(6):637-9. PubMed ID: 9230795
[TBL] [Abstract][Full Text] [Related]
5. Systemic efficacy on
Diawara EH; François A; Stachulski AV; Razakandrainibe R; Costa D; Favennec L; Rossignol JF; Gargala G
Parasitology; 2021 Jul; 148(8):975-984. PubMed ID: 33775260
[TBL] [Abstract][Full Text] [Related]
6. Amixicile Reduces Severity of Cryptosporidiosis but Does Not Have
Bartelt LA; Bolick DT; Kolling GL; Stebbins E; Huston CD; Guerrant RL; Hoffman PS
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297368
[No Abstract] [Full Text] [Related]
7. The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis.
Lee S; Harwood M; Girouard D; Meyers MJ; Campbell MA; Beamer G; Tzipori S
PLoS One; 2017; 12(10):e0185906. PubMed ID: 28973041
[TBL] [Abstract][Full Text] [Related]
8. Drug treatment and novel drug target against Cryptosporidium.
Gargala G
Parasite; 2008 Sep; 15(3):275-81. PubMed ID: 18814694
[TBL] [Abstract][Full Text] [Related]
9. Role of wheat germ agglutinin (WGA) in treatment of experimental cryptosporidiosis.
Moustafa MA
J Egypt Soc Parasitol; 2003 Aug; 33(2):443-56. PubMed ID: 14964659
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model.
Blagburn BL; Drain KL; Land TM; Kinard RG; Moore PH; Lindsay DS; Patrick DA; Boykin DW; Tidwell RR
Antimicrob Agents Chemother; 1998 Nov; 42(11):2877-82. PubMed ID: 9797219
[TBL] [Abstract][Full Text] [Related]
12. Nitazoxanide for cryptosporidial diarrhea.
Bowers M
BETA; 1998 Apr; ():30-1. PubMed ID: 11365264
[TBL] [Abstract][Full Text] [Related]
13. A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box.
Jumani RS; Bessoff K; Love MS; Miller P; Stebbins EE; Teixeira JE; Campbell MA; Meyers MJ; Zambriski JA; Nunez V; Woods AK; McNamara CW; Huston CD
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339392
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic and therapeutic efficacy of nitazoxanide against Cryptosporidium parvum in experimentally challenged neonatal calves.
Schnyder M; Kohler L; Hemphill A; Deplazes P
Vet Parasitol; 2009 Mar; 160(1-2):149-54. PubMed ID: 19062195
[TBL] [Abstract][Full Text] [Related]
15. NTZ--we got it.
Young A
Notes Undergr; 1996 Sep; (No 33):8. PubMed ID: 11363916
[TBL] [Abstract][Full Text] [Related]
16. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
[TBL] [Abstract][Full Text] [Related]
17. Piperazine-Derivative MMV665917: An Effective Drug in the Diarrheic Piglet Model of Cryptosporidium hominis.
Lee S; Ginese M; Girouard D; Beamer G; Huston CD; Osbourn D; Griggs DW; Tzipori S
J Infect Dis; 2019 Jun; 220(2):285-293. PubMed ID: 30893435
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
Abdou AG; Harba NM; Afifi AF; Elnaidany NF
Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034
[TBL] [Abstract][Full Text] [Related]
19. Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
Hulverson MA; Vinayak S; Choi R; Schaefer DA; Castellanos-Gonzalez A; Vidadala RSR; Brooks CF; Herbert GT; Betzer DP; Whitman GR; Sparks HN; Arnold SLM; Rivas KL; Barrett LK; White AC; Maly DJ; Riggs MW; Striepen B; Van Voorhis WC; Ojo KK
J Infect Dis; 2017 Apr; 215(8):1275-1284. PubMed ID: 28329187
[TBL] [Abstract][Full Text] [Related]
20. Bobel-24 activity against Cryptosporidium parvum in cell culture and in a SCID mouse model.
Rueda C; Fenoy S; Simón F; Del Aguila C
Antimicrob Agents Chemother; 2008 Mar; 52(3):1150-2. PubMed ID: 18160525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]